Notably, BNIP3 is a well-known HIF-1α target gene and its expression, together with the consequent mitophagy activation and inhibition of c-Myc-dependent mitochondrial biogenesis, promotes cancer progression and resistance to chemotherapy [37]. This evidence concerns the gene HIF1A and cancer.